arrow

From NeuroLex

Jump to: navigation, search



Acitretin

Name: Acitretin
Description: An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate. (PubChem) Pharmacology: Acitretin is a retinoid. Retinoids have a structure similar to vitamin A and are involved in the normal growth of skin cells. Acitretin works by inhibiting the excessive cell growth and keratinisation (process by which skin cells become thickened due to the deposition of a protein within them) seen in psoriasis. It therefore reduces the thickening of the skin, plaque formation and scaling. Mechanism of action: The mechanism of action of acitretin is unknown, however it is believed to work by targeting specific receptors (retinoid receptors) in the skin which help normalize the growth cycle of skin cells. Drug type: Approved. Small Molecule. Drug category: Keratolytic Agents
Synonym(s): Acetretin, Soriatane
Has role: Drug
Super-category: Molecular entity
URL: http://www.drugbank.ca/drugs/DB00459
Id: CHEBI:50172
Related to: Retinoic acid receptor RXR-beta, Retinoic acid receptor gamma-1, Retinoic acid receptor beta, Retinoic acid receptor gamma-2, Retinoic acid receptor RXR-alpha, Serum albumin, Retinoic acid receptor alpha, Retinoic acid receptor RXR-gamma
Link to OWL / RDF: Download this content as OWL/RDF




bookmark
Facts about AcitretinRDF feed
Commenttaken from DrugBank
CurationStatusuncurated  +
CuratorAb  +
DefiningCitationhttp://www.drugbank.ca/drugs/DB00459  +
DefinitionAn oral retinoid effective in the treatmen An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate. (PubChem) Pharmacology: Acitretin is a retinoid. Retinoids have a structure similar to vitamin A and are involved in the normal growth of skin cells. Acitretin works by inhibiting the excessive cell growth and keratinisation (process by which skin cells become thickened due to the deposition of a protein within them) seen in psoriasis. It therefore reduces the thickening of the skin, plaque formation and scaling. Mechanism of action: The mechanism of action of acitretin is unknown, however it is believed to work by targeting specific receptors (retinoid receptors) in the skin which help normalize the growth cycle of skin cells. Drug type: Approved. Small Molecule. Drug category: Keratolytic Agents olecule. Drug category: Keratolytic Agents
Has roleDrug  +
IdCHEBI:50172  +
LabelAcitretin  +
ModifiedDate12 August 2014  +
RelatedToRetinoic acid receptor RXR-beta  +, Retinoic acid receptor gamma-1  +, Retinoic acid receptor beta  +, Retinoic acid receptor gamma-2  +, Retinoic acid receptor RXR-alpha  +, Serum albumin  +, Retinoic acid receptor alpha  +, and Retinoic acid receptor RXR-gamma  +
SuperCategoryMolecular entity  +
SynonymAcetretin  +, and Soriatane  +